Condition: PARKINSON DISEASE (Disorder) · Apathy · Safety · Sponsor: Integrative Research Laboratories AB
This clinical trial's goal is to evaluate if the IRL757 is safe and has a good tolerability in participants with Parkinson's disease and experiencing apathy (a lack of interest or motivation). In addition, the trial is aiming to learn if IRL757 has effects on the symptoms of Parkinson's disease. Researchers will compare the effects of IRL757 to a placebo (a look-alike substance that contains no drug). Participants who fit the study criteria will be treated with the study drug (either the active drug IRL757 or placebo) for 12 weeks and will visit the clinic at 5 defined timepoints for check-ups and tests. A follow-up call after the end of treatment will be done 4 weeks after the last study drug intake.
This description comes directly from the study's public registry record.
Joakim Tedroff · +46 31 757 38 00 · info@irlab.se
Always discuss trial participation with your own doctor first.
| Medical Center "Galileo" OOD | Pleven, Bulgaria | Recruiting |
| First University Multiprofile Hospital for Active Treatment MHAT - Neurology Clinic | Sofia, Bulgaria | Recruiting |
| University Multiprofile Hospital for Active Treatment "Alexandrovska" EAD, Clinic of Neurological Diseases | Sofia, Bulgaria | Not Yet Recruiting |
| Neurologie Berlin | Berlin, Germany | Recruiting |
| Universitaetsklinikum Carl Gustav Carus | Dresden, Germany | Not Yet Recruiting |
| Centrum Medyczne NEUROMED | Bydgoszcz, Poland | Recruiting |
| Neuro-Care sp. z o.o. sp. Komandytowa | Katowice, Poland | Recruiting |
| NeuroKlinika Prof. Andrzej Bogucki | Lodz, Poland | Recruiting |
| EuroMedis Sp. z o.o. | Szczecin, Poland | Recruiting |
| Centrum Medyczne NeuroProtect | Warsaw, Poland | Not Yet Recruiting |
| Hospital de la Santa Creu i Sant Pau, Unidad de trastornos del movimiento | Barcelona, Spain | Recruiting |
| Hospital General Universitario de Elche | Elche, Spain | Not Yet Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07461220